Performa Ltd (US)’s Clover Health Investments CLOV Stock Holding History

Performa Ltd (US)’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.1K	Hold	8,000	–	–	﹤0.01%	26
2025 Q4	$18.8K	Buy	+8,000	New	+$21.9K	﹤0.01%	23
2025 Q1	–	Sell	-9,250	Closed	-$29.1K	–	54
2024 Q4	$29.1K	Sell	9,250 -44,750	-83%	-$160K	0.01%	22
2024 Q3	$152K	Sell	54,000 -46,000	-46%	-$105K	0.06%	18
2024 Q2	$123K	Buy	100,000 +12,500	+14%	+$11.2K	0.05%	19
2024 Q1	$69.5K	Buy	87,500 +10,000	+13%	+$9.1K	0.03%	20
2023 Q4	$73.8K	Buy	77,500 +7,500	+11%	+$7.37K	0.03%	19
2023 Q3	$75.6K	Hold	70,000	–	–	0.04%	19
2023 Q2	$62.8K	Buy	70,000 +5,000	+8%	+$4.43K	0.03%	18
2023 Q1	$54.9K	Buy	65,000 +7,000	+12%	+$7.66K	0.03%	19
2022 Q4	$53.9K	Buy	58,000 +19,000	+49%	+$25.4K	0.03%	21
2022 Q3	$66K	Sell	39,000 -1,000	-3%	-$2.62K	0.04%	17
2022 Q2	$86K	Buy	40,000 +10,000	+33%	+$26.6K	0.06%	16
2022 Q1	$107K	Buy	30,000 +20,000	+200%	+$58K	0.08%	16
2021 Q4	$37K	Buy	10,000 +8,800	+733%	+$54K	0.02%	22
2021 Q3	$9K	Buy	1,200 +950	+380%	+$8.13K	0.01%	27
2021 Q2	$3K	Sell	250 -1,050	-81%	-$10.3K	﹤0.01%	25
2021 Q1	$10K	Buy	+1,300	New	+$14.7K	0.01%	9

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Performa Ltd (US)'s CLOV Position: Q1 2026 in Review

Performa Ltd (US) held its Clover Health Investments (CLOV) position steady in Q1 2026 at 8,000 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #26.

Performa Ltd (US) first reported a position in CLOV in Q1 2021 and has held it in 18 quarters since. The position peaked at $152K in Q3 2024. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

Performa Ltd (US) held 8,000 shares of Clover Health Investments worth $14.1K as of Q1 2026.
Performa Ltd (US) left its Clover Health Investments share count unchanged in Q1 2026.
Clover Health Investments made up ﹤0.01% of Performa Ltd (US)'s portfolio in Q1 2026, its #26 holding.
Performa Ltd (US) first reported a position in Clover Health Investments in Q1 2021 and has held it in 18 quarters since.
Performa Ltd (US)'s Clover Health Investments position peaked at $152K in Q3 2024.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Performa Ltd (US)'s 13F filing for Q1 2026, filed 6 May 2026.